CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following Transplantation

Background. Donor-specific antibodies (DSA) are a recognized cause of allograft injury, yet biomarkers that indicate their development posttransplant or guide management are not available. CXCL13 (chemokine [C-X-C motif] ligand 1) is a chemoattractant produced within secondary lymphoid organs necess...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Emma S. Crichton, MD, MPH, Shan Zeng, MD, PhD, G. Michael La Muraglia, II, PhD, I. Raul Badell, MD
Format: article
Langue:EN
Publié: Wolters Kluwer 2021
Sujets:
Accès en ligne:https://doaj.org/article/944df3f4cb9c4559bf0b7959bcd41b16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!